Literature DB >> 10403523

Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.

V Hélin1, M Gottikh, Z Mishal, F Subra, C Malvy, M Lavignon.   

Abstract

Factors limiting the use of antisense phosphodiester oligodeoxynucleotides (ODNs) as therapeutic agents are inefficient cellular uptake and intracellular transport to RNA target. To overcome these obstacles, ODN carriers have been developed, but the intracellular fate of ODNs is controversial and strongly depends on the means of vectorization. Polyamidoamine dendrimers are non-linear polycationic cascade polymers that are able to bind ODNs electrostatically. These complexes have been demonstrated to protect phosphodiester ODNs from nuclease degradation and also to increase their cellular uptake and pharmacological effectiveness. We studied the intracellular distribution of a fluorescein isothiocyanate-labeled ODN vectorized by a dendrimer vector and found that intracellular ODN distribution was dependent on the phase of the cell cycle, with a nuclear localization predominantly in the G2/M phase. In addition, in order to evaluate the relevance of ODN vectors in enhancing the inhibition of the targeted genes' expression, we developed a rapid screening system which measures the transient expression of two reporter genes, one used as target, the other as control and vice versa. This system was validated through investigating the effect of the dendrimer vector on ODN biological activity. Antisense sequence-specific inhibition of more than 70% of one reporter gene was obtained with a chimeric ODN containing four phosphorothioate groups, two at each end.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403523     DOI: 10.1016/s0006-2952(99)00083-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers.

Authors:  H Yoo; R L Juliano
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

Review 2.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

3.  Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity.

Authors:  Sumati Sundaram; Li Kim Lee; Charles M Roth
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

4.  Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.

Authors:  Valeria Márquez-Miranda; Juan Pablo Peñaloza; Ingrid Araya-Durán; Rodrigo Reyes; Soledad Vidaurre; Valentina Romero; Juan Fuentes; Francisco Céric; Luis Velásquez; Fernando D González-Nilo; Carolina Otero
Journal:  Nanoscale Res Lett       Date:  2016-02-04       Impact factor: 4.703

Review 5.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.